Ashish M. Kamat, MD | Authors

Venous Thromboembolism and Bleeding Risk in Bladder Cancer

October 15, 2014

Despite the higher risk of VTE in patients with bladder cancer, ironically, their risk of bleeding and anemia, and greater need for transfusion of blood products, poses an equally significant risk of morbidity and mortality, especially among those who undergo cystectomy.

Contemporary Management of Locally Invasive Bladder Cancer

December 16, 2011

Muscle-invasive bladder cancer is an aggressive and potentially lethal disease. Integration of multimodal therapies, improved surgical techniques, and utilization of targeted agents has tremendously improved outcomes.

Bladder Cancer: Imperatives for Personalized Medicine

September 15, 2011

Wide variations in the care of early bladder cancer exist, and among high–treatment intensity urology providers, overall survival is unchanged while rates of transition to major surgery are actually increasing. It has been said that for bladder tumors, it is time for a paradigm shift. We believe that the time is overdue.